Skip to main content
Jens Folke Kiilgaard on Muck Rack

Jens Folke Kiilgaard

As seen in: Nature, American Journal of Ophthalmology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jens Folke

Contact Jens Folke, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Endoresection of choroidal melanoma: practical and safety considerations - Eye

|
By Rodrigo Anguita, Jens Folke Kiilgaard
| Nature Verified
Endoresection of choroidal melanoma (CM) was first described by Peyman and Cohen in 1986 [1]. However, it was Damato in 1998 who popularised the term “endoresection” and standardised the surgical approach [2]. This technique has since evolved and has been used as an alternative to enucleation and radiotherapy and in cases complicated by radiation-induced toxic tumour syndrome (TTS).
Open in Who Shared Issue with article?

Increasing Incidence of Posterior Uveal Melanoma in Scandinavia 1960-2022: A Tri-National Study

|
By Jens Folke Kiilgaard, Maria Fili, Stefan Seregard
| American Journal of Ophthalmology Verified
Original ArticlesVolume 274p131-141Open access Affiliations & Notes 1From the Department of Ophthalmology (K.N., J.F.K.), Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark 2Ocular Oncology Service (M.F., G.S.), St. Erik Eye Hospital, Stockholm, Sweden 3Department of Clinical Neuroscience (M.F., S.S., G.S.), Karolinska Institute, Stockholm, Sweden 4Department of Ophthalmology (J.N.), Institute of Clinical Medicine, University of Oslo, Oslo, Norway 5Department of Ophthalmology...
Open in Who Shared Issue with article?

18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma - Scientific Reports

|
By Tine Gadegaard Hindso, Torben Martinussen, Annika Loft, Kristoffer Nissen, Carsten Faber, Marco Donia, Inge Marie Svane, Eva Ellebaek, Jens Folke Kiilgaard, Sune Høgild Keller, Mette Bagger Sjøl
| Nature Verified
Abstract The prognostic value of metabolic tumor burden parameters obtained from 18F-FDG PET/CT imaging was evaluated in this retrospective national multicenter study of patients with metastatic posterior uveal melanoma (PUM) and compared to the largest diameter of the largest metastatic lesion (LDLM) and the American Joint Committee on Cancer (AJCC) staging system.
Open in Who Shared Issue with article?
See all 5 articles